Published: 2018-12-08

Articles

BUILDING A STRUCTURED MONITORING AND EVALUATING SYSTEM OF POSTMARKETING DRUG USE IN SHANGHAI

Wenmin Du, Mitchell Levine, Longxing Wang, Chengdong Yi, Hongmin Wang, Xiaoyu Wang, Hongjuan Xie Xie, Jianglong Xu, Huilin Jin, Tongchun Wang, Gang Huang, Ye Wu
Abstract 180 | PDF Downloads 136

COUNSELING REGARDING PREGNANCY- RELATED DRUG EXPOSURES BY FAMILY PHYSICIANS IN ONTARIO

Jodi Goodwin, Scott Rieder, Michael J Rieder, Doreen Matsui
Abstract 137 | PDF Downloads 89

45 YEARS LATER… WHERE DO WE STAND?

Mercédes Benegbi
Abstract 133 | PDF Downloads 79

PAEDIATRIC ADVERSE DRUG REACTION REPORTING: UNDERSTANDING AND FUTURE DIRECTIONS

Bruce C Carleton, M Anne Smith, Michaela N Gelin, Susan C Heathcote
Abstract 428 | PDF Downloads 205

DRUGS IN PREGNANCY: ACKNOWLEDGING CHALLENGES - FINDING SOLUTIONS

Gideon Koren, Stuart MacLeod, Donald Davis
Abstract 509 | PDF Downloads 113

DRUGS USED IN PREGNANCY: THE REGULATORY PROCESS

Anne Tomalin
Abstract 162 | PDF Downloads 289

THE WAY WOMEN PERCEIVE TERATOGENIC RISK

Gideon Koren
Abstract 628 | PDF Downloads 271

INACTIVE PHARMACEUTICAL INGREDIENTS: IMPLICATIONS FOR PREGNANCY

Yaron Finkelstein, Massoud Rezvani, Facundo Garcia-Bournissen, Laila Nurmohamed, Gideon Koren
Abstract 1198 | PDF Downloads 624

CHALLENGES IN DRUG USE NEAR TERM AND DURING DELIVERY

Dan Farine
Abstract 122 | PDF Downloads 89

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 101 | PDF Downloads 79

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 118 | PDF Downloads 68

CRITICAL APPRAISAL ROUNDS: A NEW TRAINING MODEL FOR CLINICAL PHARMACOLOGISTS

Gideon Koren, Irena Nulman
Abstract 541 | PDF Downloads 94

USE OF CELECOXIB IMMEDIATELY POST MARKETING IN CANADA: ACUTE OR CHRONIC PAI N?

Anita L Kozyrskyj, Colette Raymond, Amber Racher Racher
Abstract 153 | PDF Downloads 114